m/s / COVID-19
Open Access
Issue
Med Sci (Paris)
Volume 37, Number 8-9, Août–Septembre 2021
m/s / COVID-19
Page(s) 722 - 725
Section Le Magazine
DOI https://doi.org/10.1051/medsci/2021122
Published online 04 August 2021
  1. Sokal A, Chappert P, Barba-Spaeth G, et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell 2021; 184 : 1201–13. [CrossRef] [PubMed] [Google Scholar]
  2. Gaebler C, Wang Z, Lorenzi JCC, et al. Evolution of antibody immunity to SARS-CoV-2. Nature 2021; 591 : 639–44. [CrossRef] [PubMed] [Google Scholar]
  3. Dan JM, Mateus J, Kato Y, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science 2021; 371 : eabf4063. [PubMed] [Google Scholar]
  4. Sakharkar M, Rappazzo CG, Wieland-Alter WF, et al. Prolonged evolution of the human B cell response to SARS-CoV-2 infection. Sci Immunol 2021; 6 : eabg6916. [CrossRef] [PubMed] [Google Scholar]
  5. Amanna IJ Slifka MK Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol Rev 2010 ; 236 : 125–138. [CrossRef] [PubMed] [Google Scholar]
  6. Inoue T Moran I Shinnakasu R et al. Generation of memory B cells and their reactivation. Immunol Rev 2018 ; 283 : 138–149. [CrossRef] [PubMed] [Google Scholar]
  7. Yuan M, Liu H, Wu NC, et al. Structural basis of a shared antibody response to SARS-CoV-2. Science 2020; 369 : 1119–23. [CrossRef] [PubMed] [Google Scholar]
  8. Robbiani DF, Gaebler C, Muecksch F, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 2020; 584 : 437–42. [CrossRef] [PubMed] [Google Scholar]
  9. Iyer AS, Jones FK, Nodoushani A, et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci Immunol 2020; 5 : eabe0367. [CrossRef] [PubMed] [Google Scholar]
  10. Ellebedy A, Turner J, Kim W, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature 2021 May 24. https://doi.org/10.1038/s41586-021-03647-4. [Google Scholar]
  11. Chen RE, Zhang X, Case JB, et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med 2021; 27 : 717–26. [CrossRef] [PubMed] [Google Scholar]
  12. Goel RR, Apostolidis SA, Painter MM, et al. Distinct antibody and memory B cell responses in SARS-CoV-2 naive and recovered individuals following mRNA vaccination. Sci Immunol 2021; 6 : eabi6950. [CrossRef] [PubMed] [Google Scholar]
  13. Wang Z, Schmidt F, Weisblum Y, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature 2021; 592 : 616–22. [CrossRef] [PubMed] [Google Scholar]
  14. Fauci AS. The story behind COVID-19 vaccines. Science 2021; 372 : 109. [CrossRef] [PubMed] [Google Scholar]
  15. Purtha WE Tedder TF Johnson J et al. Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants. J Exp Med 2011 ; 208 : 2599–2606. [CrossRef] [PubMed] [Google Scholar]
  16. Laffleur B Zeinab Dalloul Z Iman Dalloul I et al. Quand les gènes codant les anticorps s’adjoignent des fragments venus d’autres chromosomes. Med Sci (Paris) 2016 ; 32 : 677–680. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.